SELADELPAR LYSINE

SELADELPAR LYSINE was reported 276 times

These side effects are most commonly reported by patients taking SELADELPAR LYSINE:

# Side effect Count
0 DRUG INEFFECTIVE 26
1 BLOOD ALKALINE PHOSPHATASE INCREASED 24
2 ASPARTATE AMINOTRANSFERASE INCREASED 22
3 HEADACHE 22
4 ALANINE AMINOTRANSFERASE INCREASED 20
5 PRURITUS 20
6 DIZZINESS 18
7 FATIGUE 15
8 NAUSEA 14
9 DIARRHOEA 12
10 ABDOMINAL DISTENSION 11
11 ABDOMINAL PAIN 11
12 HEPATIC ENZYME INCREASED 10
13 ABDOMINAL PAIN UPPER 9
14 GAMMA-GLUTAMYLTRANSFERASE INCREASED 8
15 VOMITING 8
16 ALOPECIA 6
17 OFF LABEL USE 6
18 RASH 6
19 ABDOMINAL DISCOMFORT 5
20 DRUG-INDUCED LIVER INJURY 5
21 FALL 5
22 HYPERTRANSAMINASAEMIA 5
23 THERAPY NON-RESPONDER 5
24 BLOOD BILIRUBIN INCREASED 4
25 DYSPHAGIA 4
26 GLOMERULAR FILTRATION RATE DECREASED 4
27 PRODUCT STORAGE ERROR 4
28 THERAPY CESSATION 4
29 TRANSAMINASES INCREASED 4
30 ANXIETY 3
31 ARTHRALGIA 3
32 BACK PAIN 3
33 CHEST DISCOMFORT 3
34 CHROMATURIA 3
35 EYE PRURITUS 3
36 GASTROOESOPHAGEAL REFLUX DISEASE 3
37 HEPATIC FAILURE 3
38 HYPERTENSION 3
39 PAIN IN EXTREMITY 3
40 PRODUCT USE ISSUE 3
41 RENAL FAILURE 3
42 RENAL IMPAIRMENT 3
43 TREMOR 3
44 VISION BLURRED 3
45 VISUAL IMPAIRMENT 3
46 WEIGHT INCREASED 3
47 ANKLE FRACTURE 2
48 ASTHENIA 2
49 AUTOIMMUNE HEPATITIS 2
50 BILIRUBIN CONJUGATED INCREASED 2
51 BLISTER 2
52 BLOOD ALKALINE PHOSPHATASE ABNORMAL 2
53 BLOOD CREATININE INCREASED 2
54 BLOOD IMMUNOGLOBULIN M INCREASED 2
55 CARDIAC FAILURE 2
56 CHOLESTASIS 2
57 CONDITION AGGRAVATED 2
58 CONFUSIONAL STATE 2
59 CONSTIPATION 2
60 CREATINE KINASE INCREASED 2
61 DYSGEUSIA 2
62 DYSPEPSIA 2
63 DYSPNOEA 2
64 EXPOSURE VIA BREAST MILK 2
65 EYE IRRITATION 2
66 FLUID RETENTION 2
67 GAIT DISTURBANCE 2
68 GALLBLADDER DISORDER 2
69 HAEMOGLOBIN DECREASED 2
70 HEPATIC STEATOSIS 2
71 HEPATITIS 2
72 INFECTION 2
73 INJECTION SITE ERYTHEMA 2
74 INSOMNIA 2
75 LOSS OF CONSCIOUSNESS 2
76 MYALGIA 2
77 OEDEMA PERIPHERAL 2
78 PAIN 2
79 PERIPHERAL SWELLING 2
80 PRODUCT DOSE OMISSION ISSUE 2
81 SMALL INTESTINAL PERFORATION 2
82 THERAPEUTIC RESPONSE UNEXPECTED 2
83 THROAT IRRITATION 2
84 URTICARIA 2
85 VERTIGO 2
86 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2
87 ACNE 1
88 ACUTE KIDNEY INJURY 1
89 ANAEMIA 1
90 ANAPHYLACTIC REACTION 1
91 APPETITE DISORDER 1
92 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1
93 BILE DUCT STENOSIS 1
94 BILIARY OBSTRUCTION 1
95 BLOOD BILIRUBIN ABNORMAL 1
96 BLOOD GLUCOSE INCREASED 1
97 BLOOD LACTATE DEHYDROGENASE INCREASED 1
98 BLOOD PRESSURE INCREASED 1
99 BLOOD TRIGLYCERIDES INCREASED 1
100 BLOOD UREA INCREASED 1
101 BLOOD URIC ACID INCREASED 1
102 BONE PAIN 1
103 BRAIN FOG 1
104 BREAST CANCER 1
105 C-REACTIVE PROTEIN INCREASED 1
106 CARBOHYDRATE ANTIGEN 19-9 INCREASED 1
107 CARDIAC ARREST 1
108 CARDIAC DISORDER 1
109 CARDIAC FAILURE CONGESTIVE 1
110 CHEST PAIN 1
111 CHOLANGITIS ACUTE 1
112 CHRONIC DISEASE DECOMPENSATION 1
113 COGNITIVE DISORDER 1
114 CONTRAINDICATED PRODUCT ADMINISTERED 1
115 CONTUSION 1
116 CREATININE RENAL CLEARANCE DECREASED 1
117 CSF VOLUME INCREASED 1
118 DEATH 1
119 DECREASED INTEREST 1
120 DEPRESSED MOOD 1
121 DIALYSIS 1
122 DRUG INTERACTION 1
123 DRY EYE 1
124 DRY MOUTH 1
125 DRY SKIN 1
126 DYSARTHRIA 1
127 EMOTIONAL DISORDER 1
128 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 1
129 ERUCTATION 1
130 ERYTHEMA OF EYELID 1
131 EYE ALLERGY 1
132 EYE PAIN 1
133 EYELID MARGIN CRUSTING 1
134 FAECES SOFT 1
135 FLATULENCE 1
136 FUNGAL SKIN INFECTION 1
137 GASTROINTESTINAL DISORDER 1
138 GASTROINTESTINAL TUBE INSERTION 1
139 GLOMERULAR FILTRATION RATE ABNORMAL 1
140 GLOMERULAR FILTRATION RATE INCREASED 1
141 HEAD DISCOMFORT 1
142 HEART RATE DECREASED 1
143 HEPATIC CIRRHOSIS 1
144 HEPATIC ENCEPHALOPATHY 1
145 HEPATIC NECROSIS 1
146 HIP FRACTURE 1
147 HOT FLUSH 1
148 HYPERBILIRUBINAEMIA 1
149 HYPERSENSITIVITY 1
150 ILLNESS 1
151 IMPAIRED WORK ABILITY 1
152 INCONTINENCE 1
153 INFLUENZA 1
154 INFLUENZA LIKE ILLNESS 1
155 INJECTION SITE BRUISING 1
156 INJECTION SITE HAEMORRHAGE 1
157 INJECTION SITE INDURATION 1
158 INJECTION SITE MASS 1
159 INJECTION SITE PAIN 1
160 INJECTION SITE PRURITUS 1
161 INTENTIONAL PRODUCT MISUSE 1
162 INTENTIONAL PRODUCT USE ISSUE 1
163 JAUNDICE 1
164 JOINT SWELLING 1
165 LABORATORY TEST ABNORMAL 1
166 LICHEN PLANUS 1
167 LIGAMENT SPRAIN 1
168 LIVER DISORDER 1
169 LIVER FUNCTION TEST INCREASED 1
170 LIVER INJURY 1
171 LIVER TRANSPLANT 1
172 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1
173 LOWER GASTROINTESTINAL HAEMORRHAGE 1
174 LUMBAR VERTEBRAL FRACTURE 1
175 LYME DISEASE 1
176 MALAISE 1
177 MATERNAL EXPOSURE DURING PREGNANCY 1
178 MOOD SWINGS 1
179 MULTIPLE ALLERGIES 1
180 MULTIPLE SCLEROSIS 1
181 MUSCLE SPASMS 1
182 MYELOFIBROSIS 1
183 MYOSITIS 1
184 NARCOLEPSY 1
185 OCULAR DISCOMFORT 1
186 OEDEMA 1
187 OPHTHALMIC MIGRAINE 1
188 ORAL CANDIDIASIS 1
189 OSTEOPOROSIS 1
190 PALPITATIONS 1
191 PANCYTOPENIA 1
192 PARAESTHESIA 1
193 PERIORBITAL SWELLING 1
194 PLATELET COUNT DECREASED 1
195 PORTAL VEIN THROMBOSIS 1
196 PRODUCT COMPLAINT 1
197 PRODUCT DOSE OMISSION IN ERROR 1
198 PRODUCT PACKAGING QUANTITY ISSUE 1
199 PRODUCT PHYSICAL ISSUE 1
200 PRODUCT USE COMPLAINT 1
201 PRODUCT USE IN UNAPPROVED INDICATION 1
202 PSORIATIC ARTHROPATHY 1
203 PULMONARY EMBOLISM 1
204 PYREXIA 1
205 RASH MACULO-PAPULAR 1
206 RASH PRURITIC 1
207 RECTAL HAEMORRHAGE 1
208 SENSORY DISTURBANCE 1
209 SEPTIC SHOCK 1
210 SKIN DISORDER 1
211 SKIN LESION 1
212 SKIN TIGHTNESS 1
213 SLEEP DISORDER 1
214 SPINAL FRACTURE 1
215 SPONTANEOUS BACTERIAL PERITONITIS 1
216 STEVENS-JOHNSON SYNDROME 1
217 STRESS 1
218 SUBDURAL HAEMATOMA 1
219 SWELLING OF EYELID 1
220 SYSTEMIC LUPUS ERYTHEMATOSUS 1
221 THERAPY INTERRUPTED 1
222 THROMBOCYTOPENIA 1
223 THROMBOTIC THROMBOCYTOPENIC PURPURA 1
224 TINNITUS 1
225 TREATMENT NONCOMPLIANCE 1
226 UNEVALUABLE EVENT 1
227 URINARY TRACT INFECTION 1
228 VARICES OESOPHAGEAL 1
229 VIRAL INFECTION 1
230 VITREOUS FLOATERS 1
231 VULVOVAGINAL DRYNESS 1